0 Ratings

ID

16897

Description

Clozapine and Olanzapine Treatment of Aggression; ODM derived from: https://clinicaltrials.gov/show/NCT01123408

Link

https://clinicaltrials.gov/show/NCT01123408

Keywords

  1. 8/13/16 8/13/16 -
Uploaded on

August 13, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :


    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Eligibility Schizophrenia NCT01123408

    Eligibility Schizophrenia NCT01123408

    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    age: 18 to 60 years.
    Description

    Age

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0001779
    diagnosis of schizophrenia or schizoaffective disorder.
    Description

    Schizophrenia or schizoaffective disorder

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0036341
    UMLS CUI [2]
    C0036337
    aggression: one episode of physical assault directed at another person in the hospital and persistence of violence/hostility for two weeks, as evidenced by the presence of some other physical, verbal or property assault or hostility, which would result in a score of 4 or more on the positive and negative syndrome scale (panss) hostility item.
    Description

    Aggression and PANSS

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0001807
    UMLS CUI [2]
    C0451383
    Exclusion Criteria
    Description

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    patients who were hospitalized for more than a year
    Description

    Hospitalization

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0019993
    patients who had a history of nonresponse to clozapine, olanzapine or haloperidol (defined as a lack of improvement despite a contiguous adequate trial of medication)
    Description

    Nonresponse to clozapine, olanzapine or haloperidol

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C3845351
    UMLS CUI [1,2]
    C0009079
    UMLS CUI [2,1]
    C3845351
    UMLS CUI [2,2]
    C0171023
    UMLS CUI [3,1]
    C3845351
    UMLS CUI [3,2]
    C0018546
    patients who had a history of clozapine, olanzapine, or haloperidol intolerance
    Description

    Intolerance to clozapine, olanzapine, or haloperidol

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C1744706
    UMLS CUI [1,2]
    C0009079
    UMLS CUI [2,1]
    C1744706
    UMLS CUI [2,2]
    C0171023
    UMLS CUI [3,1]
    C1744706
    UMLS CUI [3,2]
    C0018546
    patients who had medical conditions that would be adversely affected by any of these three medications.
    Description

    Comorbidity

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0009488
    patients who received a depot antipsychotic within 30 days before randomization.
    Description

    Depot antipsychotic medication

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C2585377

    Similar models

    Eligibility Schizophrenia NCT01123408

    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    C1512693 (UMLS CUI)
    Age
    Item
    age: 18 to 60 years.
    boolean
    C0001779 (UMLS CUI [1])
    Schizophrenia or schizoaffective disorder
    Item
    diagnosis of schizophrenia or schizoaffective disorder.
    boolean
    C0036341 (UMLS CUI [1])
    C0036337 (UMLS CUI [2])
    Aggression and PANSS
    Item
    aggression: one episode of physical assault directed at another person in the hospital and persistence of violence/hostility for two weeks, as evidenced by the presence of some other physical, verbal or property assault or hostility, which would result in a score of 4 or more on the positive and negative syndrome scale (panss) hostility item.
    boolean
    C0001807 (UMLS CUI [1])
    C0451383 (UMLS CUI [2])
    Item Group
    C0680251 (UMLS CUI)
    Hospitalization
    Item
    patients who were hospitalized for more than a year
    boolean
    C0019993 (UMLS CUI [1])
    Nonresponse to clozapine, olanzapine or haloperidol
    Item
    patients who had a history of nonresponse to clozapine, olanzapine or haloperidol (defined as a lack of improvement despite a contiguous adequate trial of medication)
    boolean
    C3845351 (UMLS CUI [1,1])
    C0009079 (UMLS CUI [1,2])
    C3845351 (UMLS CUI [2,1])
    C0171023 (UMLS CUI [2,2])
    C3845351 (UMLS CUI [3,1])
    C0018546 (UMLS CUI [3,2])
    Intolerance to clozapine, olanzapine, or haloperidol
    Item
    patients who had a history of clozapine, olanzapine, or haloperidol intolerance
    boolean
    C1744706 (UMLS CUI [1,1])
    C0009079 (UMLS CUI [1,2])
    C1744706 (UMLS CUI [2,1])
    C0171023 (UMLS CUI [2,2])
    C1744706 (UMLS CUI [3,1])
    C0018546 (UMLS CUI [3,2])
    Comorbidity
    Item
    patients who had medical conditions that would be adversely affected by any of these three medications.
    boolean
    C0009488 (UMLS CUI [1])
    Depot antipsychotic medication
    Item
    patients who received a depot antipsychotic within 30 days before randomization.
    boolean
    C2585377 (UMLS CUI [1])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial